Job Description

We are excited to offer the role of Lead Cancer Protocol Pharmacist at the Royal Surrey Cancer Centre. This role has lead responsibility for the development of the highly regarded St Luke's systemic anti-cancer therapy (SACT) and supportive care protocols in collaboration with Consultant Oncologist/Haematologist colleagues. The post holder will manage the storage and access of protocols via the St Luke's website: https://www.royalsurrey.nhs.uk/chemotherapy-policies-and-protocols



The post holder would take a lead for entry of new medicines for Oncology/Haemato-Oncology, with opportunities to maintain clinical knowledge and skills as a specialised Oncology/Haemato-Oncology Pharmacist.

The post includes specialist clinical cancer pharmacist support to NHS England National and South East Regional Teams, as defined in a separate Service Level Agreement (0.2WTE).



The successful applicant would join an experienced team of specialist pharmacy staff who provide a comprehensive service to oncology, haemato-oncology and surgical oncology patients. You would work closely with the teams in RSCH Pharmacy Limited (the satellite dispensary) and the Aseptic Unit but this role does not include any direct responsibilities in these areas.



This post requires a postgraduate clinical pharmacy qualification and specialist experience in oncology, haemato-oncology, and palliative care. We support relevant personal/career development training and consider flexible working arrangements.



The aim of this role is to lead the development of agreed systemic anti-cancer therapy (SACT) and supportive care treatment protocols and guidelines to ensure standardised evidence-based clinical practice across St Luke's Cancer Centre and partner Cancer Units (ASPH, FPH and SASH). This includes leading on the new medicines entry process within this specialty. The post holder will maintain clinical knowledge and skills in order to perform the role of a highly specialised Oncology/Haemato-Oncology Pharmacist.



Royal Surrey is a compassionate and collaborative acute and community Trust. Recognising that our 5000 colleagues are our greatest strength, we offer a comprehensive health and wellbeing program along with a commitment to developing and advancing your career. Our diverse and welcoming Royal Surrey family will ensure you that you feel valued from your initial interview through your entire tenure.



We are clinically led and provide joined up care by bridging the gap between hospital and community services alongside regional specialist cancer care. Our main acute hospital site is in Guildford with community hospital sites at Milford, Haslemere and Cranleigh. We provide adult community health services in homes across Guildford and Waverley.



The Care Quality Commission (CQC) have given us an overall rating of Outstanding.



Royal Surrey has a strong reputation and history to build on. We are proud of our achievements and we are investing in our colleagues through our commitment to supporting professional development as well as investing more than 45 million in our physical environment and new equipment in the next few years. There has never been a better time to join us.



Although it isn't the Trusts normal practice, adverts may close early, so you are encouraged to submit an application as soon as possible.



A video about the Royal Surrey - https://www.youtube.com/watch?v=R96pMboIYdo



Responsible for the development of protocols and guidelines for the St Luke's Cancer Centre and partner Cancer Units (ASPH, FPH and SASH) in collaboration with Consultant Oncologists/Haematologists. These reference the latest clinical evidence and commissioning guidance. They include:

o Tumour site specific treatment algorithms

o Systemic anti-cancer therapy (SACT) treatment protocols

o Supportive care protocols

o Guidelines/protocols for the delivery of SACT

o Guidelines/protocols for SACT-related acute oncology presentations

o General SACT prescribing guidelines

e.g. assessment of renal function, monitoring patient weight



Responsible for monitoring deviations from the agreed treatment algorithms/protocols (off -protocol reporting). Responsible for the provision of training to medical, nursing and pharmacy staff on SACT treatment algorithms/protocols and supportive care/toxicity management guidelines. Responsible for the identification of new drug treatments or clinical guidance within the specialty that have financial implications, and support the management or implementation of these within the Trust (i.e. Horizon Scanning) in liaison with Deputy Chief Pharmacist Cancer, Aseptic and Research Services. Responsible for the new medicines entry process for SACT (including compassionate use) and associated supportive care medicines, involving liaison with other areas of Pharmacy e.g.

o Pharmacy Procurement

o Pharmacy Aseptic Unit

o Pharmacy Dispensary (RSCH Pharmacy Limited)

o Lead Electronic Prescribing Pharmacist (Chemotherapy)



Responsible for the development of SACT regimen-specific consent forms in collaboration with Consultant Oncologists/Haematologists. Liaise with commissioners as required to ensure the Cancer Centre is operating within latest commissioning guidance e.g. NHS England / local Clinical Commissioning Groups. Act as a resource in dealing with complex and contentious issues surrounding the use of high cost drugs, including the resolution of commissioner data challenges. Where required, ensure that commissioner approval at individual patient level is in place prior to treatment initiation. Identify areas of potential cost-savings within the specialty and implement systems to realise savings and contain prescribing costs. Work as a highly specialised practitioner, with tumour-site specific teams as required, to contribute to the delivery a comprehensive clinical pharmacy service to oncology, haemato-oncology and palliative care patients in accordance with objectives set by the Deputy Chief Pharmacist Cancer, Aseptic and Research Services. * Provide specialist clinical cancer pharmacist support to NHS England National Teams and the South East Regional Team with scope and responsibilities as defined in a separate Service Level Agreement (0.2WTE commitment).